Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Julie E. Stein
Observed names:
J. Stein,
J.E. Stein,
Julie S. Deutsch,
Julie E Stein,
Julie Stein,
Stein, Julie E.
show all 6
Institutions:
Johns Hopkins University,
Sidney Kimmel Comprehensive Cancer Center
Observed institutions:
Johns Hopkins University,
Beaumont Health,
Johns Hopkins Medicine,
Beaumont Hospital, Royal Oak,
Johns Hopkins Hospital,
Sidney Kimmel Comprehensive Cancer Center
show all 6
OpenAlex ID:
A5079599604
Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade
2019
·
Steve Lu
, Julie E. Stein
, et al.
·
JAMA Oncology
·
607
PDF
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
2018
·
T.R. Cottrell
, E.D. Thompson
, et al.
·
Annals of Oncology
·
589
Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma
2018
·
M.T. Tetzlaff
, J.L. Messina
, et al.
·
Annals of Oncology
·
284
PDF
Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial
2020
·
Suzanne L. Topalian
, Shailender Bhatia
, et al.
·
Journal of Clinical Oncology
·
281
PDF
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
2021
·
Robert L Ferris
, William C Spanos
, et al.
·
Journal for ImmunoTherapy of Cancer
·
228
PDF
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
2021
·
Sneha Berry
, Nicolas A. Giraldo
, et al.
·
Science
·
199
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade
2019
·
Julie E. Stein
, Evan J. Lipson
, et al.
·
Clinical Cancer Research
·
177
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
2018
·
Nicolas A. Giraldo
, Peter Nguyen
, et al.
·
Journal for ImmunoTherapy of Cancer
·
177
PDF
Interleukin-36γ–producing macrophages drive IL-17–mediated fibrosis
2019
·
Sven D. Sommerfeld
, Christopher Cherry
, et al.
·
Science Immunology
·
161
PDF
Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma
2020
·
Valsamo Anagnostou
, Daniel C. Bruhm
, et al.
·
Cell Reports Medicine
·
80
PDF
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma
2021
·
Michael A. Gorin
, Hiten D. Patel
, et al.
·
European Urology Oncology
·
79
Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response
2019
·
J.E. Stein
, A. Soni
, et al.
·
Annals of Oncology
·
73
PDF
Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas
2020
·
Farah Succaria
, Pia Kvistborg
, et al.
·
Cancer Immunology Immunotherapy
·
43
PDF
Nivolumab (Nivo) as neoadjuvant therapy in patients with resectable Merkel cell carcinoma (MCC) in CheckMate 358.
2018
·
Suzanne Louise Topalian
, Shailender Bhatia
, et al.
·
Journal of Clinical Oncology
·
40
Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery
2021
·
Nicolas A. Giraldo
, Sneha Berry
, et al.
·
Cancer Immunology Research
·
24
Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma
2020
·
Rohit Thummalapalli
, Thatcher Heumann
, et al.
·
Case Reports in Oncology
·
23
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
2019
·
Sneha Berry
, Nicolas Giraldo
, et al.
·
Journal for ImmunoTherapy of Cancer
·
23
PDF
Nivolumab (NIVO) + tacrolimus (TACRO) + prednisone (PRED) +/- ipilimumab (IPI) for kidney transplant recipients (KTR) with advanced cutaneous cancers.
2022
·
Kara M. Schenk
, Julie E. Stein
, et al.
·
Journal of Clinical Oncology
·
17
Fatal SARS-CoV-2 Inflammatory Syndrome and Myocarditis in an Adolescent: A Case Report
2020
·
Jeanette T. Beaudry
, Barbara Dietrick
, et al.
·
The Pediatric Infectious Disease Journal
·
16
A phase 2 study of nivolumab (NIVO) alone or plus ipilimumab (IPI) for patients with locally advanced unresectable (laBCC) or metastatic basal cell carcinoma (mBCC).
2019
·
Julie E. Stein
, Patricia Brothers
, et al.
·
Journal of Clinical Oncology
·
7
Survival After Chemoradiation in Resected Pancreatic Cancer: The Impact of Adjuvant Gemcitabine
2012
·
Andrew Baschnagel
, Chirag Shah
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
7
Poliosis Circumscripta: A Mark of Melanoma
2019
·
Megan D. Schollenberger
, Julie E. Stein
, et al.
·
The American Journal of Medicine
·
6
Anti-TNF therapy-induced lupus erythematosus-like syndrome in a patient treated with adalimumab for cutaneous psoriasis
2018
·
Julie E. Stein
, Jeffrey Patterson-Fortin
, et al.
·
BMJ Case Reports
·
6
PDF
Immune cell subsets in interface cutaneous immune‐related adverse events associated with anti‐PD ‐1 therapy resemble acute graft versus host disease more than lichen planus
2022
·
Guillermo E. Almodovar Cruz
, Genevieve Kaunitz
, et al.
·
Journal of Cutaneous Pathology
·
5
PDF
Abstract 6584: The ‘AstroPath' platform for spatially resolved, single cell analysis of the tumor microenvironment (TME) using multispectral immunofluorescence (mIF)
2020
·
Sneha Berry
, Nicolas Giraldo
, et al.
·
Cancer Research
·
3
Show more works
View as search
Works count:
84
Citation count:
3,160
H-index:
17
I10-index:
19
Year
Topic
Type
